Atlas Trials

Open-label, Pivotal Clinical Trial to Confirm Efficacy and Safety of Autologous Grafts Containing Stem Cells Genetically Modified for Epidermis Restoration in Patients With Junctional Epidermolysis Bullosa

Clinical trial NCT05111600 · TERMINATED

Trial details

NCT number
NCT05111600
Sponsor
Holostem s.r.l.
Status
TERMINATED
Phase
Phase 2, Phase 3
Study type
INTERVENTIONAL
Junctional Epidermolysis Bullosa Non-Herlitz Type
Start date
2022-07-15
Primary completion
2024-03-12
Enrollment
2

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.